These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24780540)

  • 41. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment.
    Giglioli C; Cecchi E; Landi D; Chiostri M; Spini V; Valente S; Gensini GF; Romano SM
    Congest Heart Fail; 2012; 18(1):47-53. PubMed ID: 22277178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
    Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F; Franco F; Cardoso JS
    Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction.
    Jia Z; Guo M; Zhang YQ; Liang HQ; Zhang LY; Song Y
    Cardiology; 2014; 128(2):195-201. PubMed ID: 24751462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamics and pharmacokinetics of oral levosimendan and its metabolites in patients with severe congestive heart failure: a dosing interval study.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    J Clin Pharmacol; 2004 Oct; 44(10):1143-50. PubMed ID: 15342615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of preoperative levosimendan therapy on the volemic status and vascular tone of patients with chronic heart failure during anesthesia].
    Aksel'rod BA; Tolstova IA; Trekova NA; Kolpakov PE; Babaev MA; Belianko IE
    Anesteziol Reanimatol; 2009; (6):46-51. PubMed ID: 20099648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
    Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
    Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
    Yontar OC; Yilmaz MB; Yalta K; Tandoğan I
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM; Akhter MW
    Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure.
    Parissis JT; Adamopoulos S; Antoniades C; Kostakis G; Rigas A; Kyrzopoulos S; Iliodromitis E; Kremastinos D
    Am J Cardiol; 2004 May; 93(10):1309-12. PubMed ID: 15135713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
    Pathak A; Lebrin M; Vaccaro A; Senard JM; Despas F
    J Clin Pharm Ther; 2013 Oct; 38(5):341-9. PubMed ID: 23594161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repetitive use of levosimendan in clinical practice: a case series.
    Wawrzyniak M; Migaj J; Straburzyńska-Migaj E; Dudek M; Kałużna-Oleksy M
    Cardiovasc J Afr; 2021 Nov-Dec 23; 32(6):339-342. PubMed ID: 33496720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaco-economics of levosimendan in cardiology: a European perspective.
    Nieminen MS; Buerke M; Parissis J; Ben-Gal T; Pollesello P; Kivikko M; Karavidas A; Severino P; Comín-Colet J; Wikström G; Fedele F
    Int J Cardiol; 2015 Nov; 199():337-41. PubMed ID: 26241640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levosimendan: current data, clinical use and future development.
    Nieminen MS; Fruhwald S; Heunks LM; Suominen PK; Gordon AC; Kivikko M; Pollesello P
    Heart Lung Vessel; 2013; 5(4):227-45. PubMed ID: 24364017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of levosimendan in patients with heart failure in different settings: case reports and treatment guidance.
    Barbici I; Hedman A; Ewaldsson CA
    Heart Lung Vessel; 2015; 7(2):143-50. PubMed ID: 26157740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levosimendan: New hope therapy for takotsubo syndrome.
    Hering D; Jaguszewski M
    Cardiol J; 2016; 23(6):616-617. PubMed ID: 27976790
    [No Abstract]   [Full Text] [Related]  

  • 60. The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.
    Nieminen MS; Fonseca C; Brito D; Wikström G
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C15-C21. PubMed ID: 29249906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.